Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone-Reference-Cited by-同舟云学术

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

Published:2023-02-23 Issue:6 Volume:22 Page:517-524
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Resál Tamás¹,Mangó Katalin²,Bacsur Péter¹^ORCID,Szántó Kata¹^ORCID,Pigniczki Daniella¹³,Keresztes Csilla⁴,Rutka Mariann¹^ORCID,Bálint Anita¹^ORCID,Milassin Ágnes¹,Bor Renáta¹^ORCID,Fábián Anna¹^ORCID,Szepes Zoltán¹,Farkas Klaudia¹^ORCID,Monostory Katalin²,Molnár Tamás¹^ORCID

Affiliation:

1. Gastroenterology, Department of Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary

2. Institute of Enzymology, Research Centre for Natural Sciences, Budapest, Hungary

3. Department of Surgery, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary

4. Department for Medical Communication and Translation Studies, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2181336

Reference32 articles.

1. Ulcerative colitis

2. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

3. Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: Overview;Current Rheumatology Reviews;2024-09